Vaccitech’s $168 Million Series B Financing Round

Vaccitech's $168 Million Series B Financing Round
Federica Tiefenthaler
Tagged:

Goodwin Procter LLP advised Vaccitech on the deal. Vaccitech announced the completion of its $168 million Series B, including the conversion of $43 million in convertible loan…

This content is for Standard 1 Year members only.
Login Join Now
Federica Tiefenthaler

Author: Federica Tiefenthaler

…

This content is for Standard 1 Year members only.
Login Join Now